Anti-tgf-beta Antibody For The Treatment Of Fanconi Anemia


The present invention provides methods of treating, preventing or delaying the onset of bone marrow failure in Fanconi Anemia patients comprising administering to the patient a composition comprising a neutralizing anti-TGF-beta antibody, e.g. fresolimumab or 1D11.

Download PDF
Document Preview
Document History
  • Publication: Sep 1, 2016
  • Application: Feb 25, 2016
    WO US 2016/0019626 W
  • Priority: Feb 25, 2015
    US US 201562120596 P

Sign in to the Lens

Release 5.10.0: Improved patent search performance, saved query alerts, increased user privacy and more!

Improved Search Performance

Upgraded patent search index servers to improve search performance.

Saved Query Alerts.

Improvements to in saved query alerts emails and better formatting of links.

Increased User Privacy.

Removed Google Maps dependency in a Patents Family page.